HIT

Strong SellSinker

Health In Tech, Inc. · Technology · United States · $58M cap · $160K/day traded

$0.5359 -4.6% · close 26 Oct · scored 27 Oct

StockRank up 1.1 since 24 Oct.

Sinker: Weak, expensive and falling. Nothing here to keep it afloat.

18
StockRank
Get score and insider alerts
Quality
47
Value
37
Momentum
14

As of 27 Oct 2026, MoatMap's StockRank for Health In Tech, Inc. (HIT) is 18/100, ranked against 24,000+ stocks in 35 markets (Quality 47, Value 37, Momentum 14, each scored against its sector).

Does StockRank work? Each month we publish how every decile did, whichever way it went. See the record →

P/E (TTM)
—
peers 32.5x
ROE
-21.9%
peers 4.9%
D/E
0.0x
peers 0.3x
Dividend %
—
trailing yield

ABOUT HEALTH IN TECH, INC.

Read

Health In Tech, Inc. develops innovative technology solutions for the healthcare industry, such as AI-driven diagnostics or telemedicine platforms, aiming to improve patient outcomes and operational efficiency. Its competitive moat often lies in proprietary algorithms, specialized medical expertise, or unique data sets that provide a distinct advantage. The company is positioned as a niche innovator leveraging technology to transform specific segments of the healthcare value chain.

FINANCIAL SUMMARY (USD)

Year2022202320242025CAGRTTM2026E2027EFwd CAGR
Revenue5.8M19.2M19.5M33.3M79.4%32.8M31.8M54.1M27.4%
EPS0.000.050.010.02138.5%-0.07-0.110.0441.4%
Shares54.1M54.1M54.6M57.7M+6.7%53.6M———
Debt0.3M1.9M0.2M0.1M-23.8%0.1M———
Equity1.1M6.1M13.2M17.1M153.5%————
Op CF0.8M1.5M2.2M3.1M58.8%-5.1M———
Inv CF-1.2M-1.9M-0.8M-3.1M—————
Fin CF1.9M1.3M4.1M-0.2M—————
Loading 1Y...
PRICE (1Y) · USD-39.5%
0.50.60.70.80.915 Sep6 Oct26 Oct
SMA 50SMA 200

Price checkStill fallingExperimental

Made a new 52-week low 3 trading days ago, 83% below its 52-week high. The fall has not stopped yet.

SwingsVery bumpy

Swung more than 93% of stocks we rank over the past year (92% a year).

How this is worked out

StockRank judges the business. The price check reads only the chart: it is the price side of the Momentum score, in words.

The rules: Still falling is a new 52-week low in the last two weeks, at least 25% below the high. Finding a floor is no new low since. Turning up is 20 or more trading days without a new low, at least 10% off it, and back above a rising 50-day average. In an uptrend is above the 200-day average and within 15% of the high.

In 2,112 US drawdowns since 2001, buying while the price was still falling was followed by a further 20% drop 42% of the time. Waiting for a turn like this one cut that to 33%, at about 7% higher prices and with no better returns. Part of that cut is simply not buying: 13% of falls never turned, and waiting kept those out. Among turns that were bought, 38% still fell another 20%, and 33% of turns were followed by a new low within six months. The benefit was largest in crashes such as 2008 and 2020.

What it measures: day-to-day price moves over the past year, as a yearly figure, ranked against every stock we cover. Very calm under 20% a year, Calm 20 to 30%, Average 30 to 40%, Bumpy 40 to 55%, Very bumpy above that.

What we found: across about 13,500 stocks in 34 markets (2002 to 2025), past swings were a good guide to the next year's, and bumpier stocks fell further. How much further changed too much between eras to put a number on it.

Calm is not safe: a calm stock can still slide steadily.

Rules fixed before any data was fetched. Describes the chart, not a recommendation.

Close
$0.5359
RSI (14)
15.0
52-Week Range-82.8% from high
Low $0.5High $3.12

SCORE BREAKDOWN

Quality
47
ROIC
-6.5%16.1
ROE
-21.9%9.4
GP/Assets
76.7%96.8
Op. Margin
-42.7%8.0
FCF/Assets
-15.4%8.6
Piotroski
659.5
Int. Cover
50.0x84.8
D/E Ratio
0.01x90.7
Current Ratio
2.18x56.5
Value
37
P/E (TTM)
—N/A
EV/EBITDA
—N/A
P/FCF
—N/A
P/B
1.9x68.9
P/S
1.1x75.2
Div Yield
—N/A
Momentum
14
52W High %
17%1.8
RS 6M
-71%2.5
SMA 50/200
0.72x5.5
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+71%49.5
Q Growth
—N/A

FUNDAMENTALS

Market Cap
$58M
P/E (Forward)
-28.1x
Gross Margin
53.9%

SECTOR PEERS

Closest peers in Technology, ranked by industry match, size, and score similarity. Cross-listings of HIT are excluded.

TickerCompanyMkt CapStockRankSignal
HITHealth In Tech, Inc.(you)$58M18Strong Sell
SCORcomScore, Inc.$75M20Sell
BZAIBlaize Holdings, Inc.$80M16Strong Sell
VIDAVIDA Global Inc.$54M10Strong Sell
RDZNRoadzen, Inc.$96M21Sell
FRMMForum Markets, Incorporated$68M7Strong Sell
RTBRTB Digital, Inc.$115M15Strong Sell
AIBAIB Data Centers Inc.$134M16Strong Sell
IMP.TOIntermap Technologies Corporation$40M7Strong Sell
HUCKHuckleberry.ai, Inc.$146M17Strong Sell

Peer medians: ROE 4.9% · P/E 32.5x · Gross margin 52.2%

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

Health In Tech, Inc. (HIT): Stock Score Summary

Health In Tech, Inc. (HIT) has a MoatMap StockRank of 18/100 based on Quality (47/100), Value (37/100), and Momentum (14/100) factor scores. The current signal is STRONG SELL.

Health In Tech, Inc. develops innovative technology solutions for the healthcare industry, such as AI-driven diagnostics or telemedicine platforms, aiming to improve patient outcomes and operational efficiency. Its competitive moat often lies in proprietary algorithms, specialized medical expertise, or unique data sets that provide a distinct advantage. The company is positioned as a niche innovator leveraging technology to transform specific segments of the healthcare value chain.

Key Financial Metrics

Price$0.5359
Market Cap$58M
P/E (Forward)-28.12
Price/Book1.89
Return on Equity-21.9%
Return on Invested Capital-6.5%
Debt/Equity0.01x
Gross Margin53.9%
Operating Margin-42.7%
Revenue Growth-13.5%
Free Cash Flow$-4M

Health In Tech, Inc. operates in the Software - Application industry, part of the Technology sector (United States).

Frequently Asked Questions

What is Health In Tech, Inc.’s (HIT) StockRank?
MoatMap’s StockRank for Health In Tech, Inc. (HIT) is 18/100, with a Strong Sell signal. It is a composite of Quality (47), Value (37), and Momentum (14), each scored against its sector. The composite is then ranked across MoatMap’s universe of 24,000+ stocks.
Does Health In Tech, Inc. have an economic moat?
Health In Tech, Inc. (HIT) has a Quality factor score of 47/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Health In Tech, Inc. a buy, hold, or sell?
MoatMap’s current signal for Health In Tech, Inc. (HIT) is Strong Sell, based on a StockRank of 18/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Health In Tech, Inc. in?
Health In Tech, Inc. (HIT) operates in the Technology sector, specifically the Software - Application industry (United States).